Measurement of human factor IXa activity in an isolated factor X activation system.
To determine the functional properties of factor IX isolated from the plasma of CRM+ hemophilia B patients, an assay system using proteins isolated from human plasma had to be developed which would be amenable to kinetic studies under a variety of experimental conditions. The present study describes the activation of factor X by factor IXa, isolated from normal human plasma, in an assay system which allows manipulation of calcium, phospholipid and factor VIIIa concentrations. Initial rate measurements with factor VIIIa present in the system were made by incubating factor VIII with factor Xa immediately before factor IXa assay. With this approach, the initial rate of factor X activation was constant, with little evidence for a lag period. Within the framework of the assay system described in the present study, it should be possible to examine not only genetic variants of factor IX, but also variants of factor VIII, as well as providing a means of routine factor IXa and factor VIII(a) assays.
D001780:Blood Coagulation Tests / Q000379:methods*; D002118:Calcium / Q000494:pharmacology; D005164:Factor IX / Q000032:analysis*; D015949:Factor IXa; D005169:Factor VIII / Q000032:analysis / Q000494:pharmacology; D015944:Factor VIIIa; D005170:Factor X / Q000032:analysis* / Q000494:pharmacology; D015951:Factor Xa; D006801:Humans; D007700:Kinetics; D010743:Phospholipids / Q000494:pharmacology
D010743:Phospholipids; D015944:Factor VIIIa; D005169:Factor VIII; D005164:Factor IX; D005170:Factor X; D015949:Factor IXa; D015951:Factor Xa; D002118:Calcium